These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
129 related articles for article (PubMed ID: 2198563)
1. Evaluation of drugs in Alzheimer's disease and age-associated memory impairment. Crook TH; Johnson BA; Larrabee GJ Psychopharmacol Ser; 1990; 8():37-55. PubMed ID: 2198563 [No Abstract] [Full Text] [Related]
2. Pharmacotherapy of cognitive deficits in Alzheimer's disease and age-associated memory impairment. Crook T Psychopharmacol Bull; 1988; 24(1):31-8. PubMed ID: 3290945 [No Abstract] [Full Text] [Related]
3. Predictors of perceived memory impairment: do they differ in Alzheimer's disease versus normal aging? Brustrom JE; Ober BA J Clin Exp Neuropsychol; 1998 Jun; 20(3):402-12. PubMed ID: 9845166 [TBL] [Abstract][Full Text] [Related]
4. [News on the Alzheimer's disease]. Féger J Ann Pharm Fr; 2009 Mar; 67(2):67-8. PubMed ID: 19298888 [No Abstract] [Full Text] [Related]
6. [Sleep and episodic memory: a review of the literature in young healthy subjects and potential links between sleep changes and memory impairment observed during aging and Alzheimer's disease]. Rauchs G; Harand C; Bertran F; Desgranges B; Eustache F Rev Neurol (Paris); 2010 Nov; 166(11):873-81. PubMed ID: 20447667 [TBL] [Abstract][Full Text] [Related]
7. [Clinical differences in senile dementia of the Alzheimer's type and in multi-infarct dementia]. Bukatina EE; Grigor'eva IV; Smirnov OV Zh Nevrol Psikhiatr Im S S Korsakova; 1994; 94(1):38-42. PubMed ID: 8009931 [TBL] [Abstract][Full Text] [Related]
8. [Pharmacological study of the amerliorative effects of Yokukansan on memory impairment and the behavioral and psychological symptoms of dementia in AD models]. Kubota K; Nogami A; Takasaki K; Katsurabayashi S; Mishima K; Fujiwara M; Iwasaki K Nihon Yakurigaku Zasshi; 2014 Mar; 143(3):110-4. PubMed ID: 24614632 [No Abstract] [Full Text] [Related]
9. Failure of nalmefene and estrogen to improve memory in Alzheimer's disease. Weiss BL Am J Psychiatry; 1987 Mar; 144(3):386-7. PubMed ID: 3548443 [No Abstract] [Full Text] [Related]
10. Nasal Colivelin treatment ameliorates memory impairment related to Alzheimer's disease. Yamada M; Chiba T; Sasabe J; Terashita K; Aiso S; Matsuoka M Neuropsychopharmacology; 2008 Jul; 33(8):2020-32. PubMed ID: 17928813 [TBL] [Abstract][Full Text] [Related]
12. Memory problems in dementia: adaptation and coping strategies and psychosocial treatments. Dröes RM; van der Roest HG; van Mierlo L; Meiland FJ Expert Rev Neurother; 2011 Dec; 11(12):1769-81; quiz 1782. PubMed ID: 22091600 [TBL] [Abstract][Full Text] [Related]
13. A modified formulation of Chinese traditional medicine improves memory impairment and reduces Aβ level in the Tg-APPswe/PS1dE9 mouse model of Alzheimer's disease. Jeon S; Bose S; Hur J; Jun K; Kim YK; Cho KS; Koo BS J Ethnopharmacol; 2011 Sep; 137(1):783-9. PubMed ID: 21762767 [TBL] [Abstract][Full Text] [Related]
15. Alzheimer's disease risk factors as mediators of subjective memory impairment and objective memory decline: protocol for a construct-level replication analysis. Hill NL; Mogle J BMC Geriatr; 2018 Oct; 18(1):260. PubMed ID: 30373526 [TBL] [Abstract][Full Text] [Related]
16. FASTKD2 and human memory: functional pathways and prospects for novel therapeutic target development for Alzheimer's disease and age-associated memory decline. Ramanan VK; Saykin AJ Pharmacogenomics; 2015; 16(5):429-32. PubMed ID: 25916514 [No Abstract] [Full Text] [Related]